Mersana Therapeutics, Inc. (MRSN)
28.23
+0.12
(+0.43%)
USD |
NASDAQ |
Dec 11, 16:00
28.24
+0.01
(+0.04%)
After-Hours: 20:00
Mersana Therapeutics Research and Development Expense (Quarterly): 12.07M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Day One Biopharmaceuticals, Inc. | 31.42M |
| Cidara Therapeutics, Inc. | 35.53M |
| Cue Biopharma, Inc. | 4.686M |
| Scholar Rock Holding Corp. | 50.06M |
| ETHZilla Corp. | -- |